Ante la incertidumbre de ciertos sectores de la sociedad respecto de si vacunar a los niños, niñas y adolescentes contra el SARS-CoV-2 es seguro o no, una discusión que fue cruzada por tensiones políticas, este martes la Sociedad Argentina de Pediatría (SAP) compartió un documento con una serie de argumentos para reafirmar que proteger a los más chicos ante el covid-19 es seguro y eficaz.
Thus, the organization has brought a vaccine for the youngest of the sea with Sinopharm, a vaccine approved for the organization between the ages of 3 and 11, or with Pfizer or Moderna, vaccines approved especially for other young people from 12 to 17 years old. in the face of the doubts of certain parents’ organizations promoted by the opposition.
As stated in the initial map of the SAP, “vaccination has been shown to be and effective” in youngsters and young people, which means the operation of the Chinese Sinopharm suero – one that uses an inactivated virus platform – in the procedure of vaccinating minors.
During their moment of separation, SAP recovered that the burden of disease in young people is lower in adults, and they can also infect and transmit the virus to other people.
In addition, given the “multiple social interactions” of young people in a context where the adults guilty of these activities are well vaccinated, the youngest “seem to be the most likely organization to fight the infection. “
“Active protection and effective vaccines will also help protect children from the appearance of new variants, Delta or Gamma, among others, which spread more easily in the pediatric population, which for now is not completely empty,” adds the SAP to feed The need for pediatric vaccination.
Finally, he also points out that vaccination of older friends strengthens “other obviously related secondary benefits”, he says such as:
“All vaccines against Covid-19 used in our country involve inactivated viruses or viral genetic material, since the ability to cause immunity at the mucosal site does not occur with other attenuated viruses,” the SAP said in its press release. .
In fact, this generates a basic “epidemiological bar” that, due to society’s high vaccination policy, hinders the transmission of SARS-CoV-2. To achieve this goal, but not to be an obstacle, it is best not to protect herd immunity as much as possible.
Covid vaccination in minors: young people aged 3 to 11 years old in the country are vaccinated
Regarding the vaccines that will be available in Argentina, the SAP has also provided a series of issues that ensure the protection and efficacy of the vaccines:
Además, el organismo especificó el proceso de vacunación en menores que se está llevando a cabo actualmente en el país y su evolución histórica: “En la República Argentina, en agosto de 2021 comenzó la vacunación de niñas, niños y adolescentes entre 12 a 17 años con comorbilidades, luego se continuó vacunando al mismo grupo etario sin comorbilidades con vacunas de RNA mensajero (Spikevax de Moderna y Comirnaty de Pfizer) y en octubre de 2021 se inició la vacunación en niñas y niños de 3 a 11 años con vacuna Sinopharm”, recuerda el comunicado de la SAP.
First, you should know that young people vaccinated with the first dose must obtain their complete break in the corresponding period while “those who have not started the vaccination series are essential to have it. “
Although the paediatric society is under pressure to guarantee precisely “vigilance in terms of the protection and efficacy of the vaccines that are being used in children, young people and adolescents”, it continues with the progress of vaccination in this age group, giving priority to young people and adolescents with chronic confinement.